Drug Profile
Ocaperidone
Alternative Names: R 79598Latest Information Update: 25 Sep 2019
Price :
$50
*
At a glance
- Originator Janssen L.P.
- Developer Evotec SE
- Class Antiemetics; Antipsychotics; Piperidines; Pyrimidinones; Small molecules
- Mechanism of Action Dopamine D2 receptor antagonists; Serotonin 5-HT2 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Psychotic disorders; Schizophrenia
Most Recent Events
- 22 Feb 2010 Discontinued - Phase-I for Psychotic disorders in Europe (PO)
- 22 Feb 2010 Discontinued - Phase-I for Psychotic disorders in USA (PO)
- 22 Feb 2010 Discontinued - Phase-II for Schizophrenia in Europe (PO)